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Opioid misuse and dependence during 
pregnancy has increased dramatically in the 
U.S. in recent years, paralleling the increase in 
opioid use disorders seen in the general U.S. 
population. This has resulted in a rapid increase 
in the number of babies who are born with 
neonatal abstinence syndrome (NAS) - 
physical dependence on opioids. Cases of NAS 
nearly doubled from 13,500 in 2009 to 
25,000 in 2016 and continue to rise.1 
Resulting from exposure to opioids in the 
womb, newborn babies begin to develop the 
symptoms of physical withdrawal within 48 
hours of birth. Symptoms include extreme 
sensitivity to touch and light, a high-pitched 
cry, an abnormally high heart rate, overactive 
reflexes, seizures, and tremors. At least 50 
percent of babies exposed to opioids during 
pregnancy will develop opioid dependency, 
increasing the risk of birth complications, low 
birth weight, respiratory problems, 
underdevelopment in the womb, and even 
death.2   
 
The Costs of NAS are Substantial 
Compared to an average 5-day hospital stay for 
newborns without NAS, opioid-exposed babies 
require an average 17-day hospital stay after 
birth. The hospital cost is more than three times 
higher for an infant born with NAS (average 
cost of $16,893) compared to an infant 
without NAS (average cost of $5,610).3 
Additional outpatient treatment after discharge 
increases the costs of NAS even more, to up to 
$238,000 above that of an unaffected 
newborn.4 Because opioid dependence is more 
prevalent among low-income populations, a 
substantial portion of the treatment costs for 
NAS fall on state Medicaid budgets. From 
2004 to 2014, NAS resulted in approximately 
$2 billion in excess Medicaid costs.5 Some state 
budgets have been hit especially hard. For 
example, NAS cost Missouri’s Medicaid budget 
$10 million in 2016. Rates of NAS in 
Pennsylvania increased by over 1,000 percent 
between 2000 and 2018, 5 with a cost of $14.1 
million to its Medicaid budget in 2017 alone.  
This added burden to state Medicaid budgets 
means that other essential services could go 
underfunded. 
 
The costs go beyond the financial. NAS 
heightens the probability of developing an 
educational disability and speech or language 
impairments in early childhood and increases 
the likelihood of requiring classroom support or 
speech therapy by a third.6 Not only does this 
increase the burden on stretched public 
resources, but it also reduces the probability 
that these children will reach their full 
productive potential. Ultimately, NAS and the 
opioid crisis more broadly have major human 
and societal costs. 
 
We Must Address the Root Causes 
of Addiction 
Many people see NAS as purely the result of a 
voluntary drug habit of an irresponsible mother. 
This view ignores the physiological and social 
realities of addiction. Addiction is a chronic 
relapsing brain disease, with roots in individual 
early-life trauma and broader economic and 
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social despair.7 Adverse childhood experiences, 
like abuse, witnessing parental domestic 
violence, and parental incarceration or death 
place children at higher risk of developing 
substance abuse and mental health disorders in 
adulthood.8 In addition, we cannot fully 
understand or reverse the opioid crisis without 
considering its social determinants. Social 
determinants of health are the structural 
conditions in which people live, work, and 
socialize that influence stress, health behaviors, 
and mortality, including economic resources, 
social relationships, and labor markets. At a 
societal level, thanks to several decades of 
economic and social decline in once thriving 
communities, many places in the U.S. were 
primed to be vulnerable to opioids – drugs that 
numb both physical and psychological pain.9 
Addressing NAS requires addressing opioid 
addiction, but more broadly requires reversing 
social and economic distress and despair. 
 
Further Action is Necessary 
There are no easy solutions to the opioid crisis. 
In the short term, strategies to reduce NAS 
should focus on encouraging stigma-free 
treatment for women with addictions who 
become pregnant. We must also understand 
that mothers continue to need support after 
delivery. By making treatment more accessible, 
women may be more inclined to seek help. This 
is gradually beginning to take place. In 2016, 
the Child Abuse Prevention and Treatment Act 
(CAPTA) was amended in conjunction with 
the Comprehensive Addiction and Recovery 
Act (CARA) to begin awarding funds to states 
in support of NAS treatment. In 2018, New 
York State allocated $3.6 million of CAPTA 
funding to the treatment of NAS and support 
for mothers with opioid addiction or 
dependence. As stipulated by CARA, this 
funding has led to the development of a 
program that will provide a plan of safe care for 
all babies identified as suffering from NAS and 
prioritizes keeping mothers with their babies 
during treatment. New York’s approach may 
become an example of the way forward, but 
there is much more to do.  
 
 
At the national level, NAS has drawn far less 
attention from policymakers than it should. A 
centralized strategy to reduce, rather than just 
treat, NAS is only starting to take shape as part 
of the SUPPORT for Patients and 
Communities Act of 2018, but this may not be 
formalized for another year. With so much at 
stake, it is important that policymakers at all 
levels take a more proactive approach to 
reverse the trend of increasing NAS rates. 
Additionally, a wholesale re-evaluation of our 
stigma toward pregnant women who use drugs 
will be necessary for any lasting impact. In 18 
states, child abuse proceedings are still explicitly 
permitted to charge pregnant women for drug 
use during pregnancy.11 Tennessee went as far 
as to introduce legislation to criminalize the use 
of opioids during pregnancy, but allowed it to 
expire in 2016 after it failed to prevent a 
continued rise in rates. It is time to critically 
reassess the idea that criminalization will reduce 
rates of addiction and NAS and begin treating 
addiction as the population health issue that it 
is. Given the human and financial costs, failure 
to effectively tackle opioid addiction and 
prevent NAS affects us all, regardless of 
whether we personally know someone who is 
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